Inside Penn

In brief, what’s happening at Penn—whether it’s across campus or around the world.

Filter Stories

Displaying 691 - 700 of 2525
  • Penn Collaboratory to fund more than $2.1M in grants in year one

    The Penn Artificial Intelligence and Technology Collaboratory for Healthy Aging (PennAITech) focuses on identifying developing, evaluating, commercializing, and disseminating innovative technology and artificial intelligence methods/software to support aging. In its first year, twelve applicants from academia, industry, and clinical practice across the U.S. have been selected for funding.

    FULL STORY AT Penn Nursing News

  • Law enforcement in the emergency department

    Police officers are commonly found in emergency departments, but hospital policy is lacking in regards to their interactions with patients.

    FULL STORY AT Leonard Davis Institute

  • DivE In event bolsters diversity and accessibility in mind-related fields

    Penn’s second annual DivE In (Diversity and Equity Initiative) weekend focused on improving diversity in fields that are related to the study of the mind, such as psychology, neuroscience, biology, linguistics, and sociology, and placing a specific focus on facilitating doctoral applications.

    FULL STORY AT OMNIA

  • Diversity in the Stacks: Diversity, equity, and inclusion in catalog searching

    Since 2021, a group of catalogers has been seeking ways to improve the language used in the Penn Libraries catalog to ensure it reflects principles of diversity, equity, and inclusion.

    FULL STORY AT Penn Libraries

  • Telemedicine program CareConnect helps eliminate barriers for opioid use disorder treatment

    CareConnect is a partnership between Penn’s 24/7 virtual urgent care, Penn Medicine OnDemand, and a team of substance use navigators. Fifty-five percent of CareConnect’s patients with opioid use disorder had an active prescription for treatment a month after first engaging with the program.

    FULL STORY AT Penn Medicine News

  • ‘Organ-on-a-chip’ device provides new insights into early-stage pregnancy

    Researchers at the Biologically Inspired Engineering Systems (BIOLines) Laboratory in the Department of Engineering in the School of Engineering and Applied Sciences have recently developed a new variation of the organ-on-a-chip: one that replicates the interface between maternal tissue and the cells of the placenta at the critical moments in early pregnancy when the embryo is implanting in the uterus.

    FULL STORY AT Penn Medicine News

  • Weitzman to honor Diller Scofidio + Renfro and Hartford400

    The 2022 Kanter Tritsch Medal in Architecture and the 2022 Witte-Sakamoto Family Medal in City and Regional Planning are two of three professional honors bestowed annually by the Weitzman School of Design. They will be presented at a ceremony which raises funds for student scholarships on Feb. 23, 2023.

    FULL STORY AT Weitzman School of Design

  • Penn Medicine receives $3.5 million NCI grant to improve cervical cancer care in Botswana

    Penn Radiation Oncology has been working with colleagues in Botswana since 2011, where the cervical cancer mortality rate is 10 times higher than the U.S.

    FULL STORY AT Penn Medicine News

  • Is there a better way to staff temporary teams?

    Research from Wharton’s Hummy Song suggests a new strategy for staffing high-performing work teams by focusing on the relationships among members and not just their skills.

    FULL STORY AT Knowledge at Wharton

  • After early potential, cholesterol medication fenofibrate fails to cut severe symptoms or death in COVID-19 patients

    The drug was initially targeted for COVID-19 research as part of an effort to test older, previously approved drugs for potential benefit against the virus. Compared with a placebo, fenofibrate had no significant effect either on severity scores or death from any cause, among other metrics. Researchers say there could be a number of potential explanations for the drug’s failure to achieve the same results in humans that it did in laboratory cells.

    FULL STORY AT Penn Medicine News